purchase customization

Leave This Empty:

choose chapter to purchase

table of content

1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Screening Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Screening Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Screening Overall Market Size
2.1 Global Prostate Cancer Screening Market Size: 2021 VS 2028
2.2 Global Prostate Cancer Screening Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Screening Players in Global Market
3.2 Top Global Prostate Cancer Screening Companies Ranked by Revenue
3.3 Global Prostate Cancer Screening Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Screening Companies in Global Market, by Revenue in 2021
3.5 Global Companies Prostate Cancer Screening Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Screening Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Screening Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Screening Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Prostate Cancer Screening Market Size Markets, 2021 & 2028
4.1.2 Physical Exam
4.1.3 Laboratory Tests
4.1.4 Imaging Tests
4.1.5 Gleason Score
4.1.6 TNM Score
4.1.7 Genetic Tests
4.1.8 Digital Rectal Exam
4.1.9 Biopsy
4.2 By Type - Global Prostate Cancer Screening Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Screening Revenue, 2017-2022
4.2.2 By Type - Global Prostate Cancer Screening Revenue, 2023-2028
4.2.3 By Type - Global Prostate Cancer Screening Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Screening Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Research Labs
5.1.5 Cancer Institutes
5.1.6 Diagnostic Centers
5.1.7 Others
5.2 By Application - Global Prostate Cancer Screening Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Screening Revenue, 2017-2022
5.2.2 By Application - Global Prostate Cancer Screening Revenue, 2023-2028
5.2.3 By Application - Global Prostate Cancer Screening Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Prostate Cancer Screening Market Size, 2021 & 2028
6.2 By Region - Global Prostate Cancer Screening Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Screening Revenue, 2017-2022
6.2.2 By Region - Global Prostate Cancer Screening Revenue, 2023-2028
6.2.3 By Region - Global Prostate Cancer Screening Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Prostate Cancer Screening Revenue, 2017-2028
6.3.2 US Prostate Cancer Screening Market Size, 2017-2028
6.3.3 Canada Prostate Cancer Screening Market Size, 2017-2028
6.3.4 Mexico Prostate Cancer Screening Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Screening Revenue, 2017-2028
6.4.2 Germany Prostate Cancer Screening Market Size, 2017-2028
6.4.3 France Prostate Cancer Screening Market Size, 2017-2028
6.4.4 U.K. Prostate Cancer Screening Market Size, 2017-2028
6.4.5 Italy Prostate Cancer Screening Market Size, 2017-2028
6.4.6 Russia Prostate Cancer Screening Market Size, 2017-2028
6.4.7 Nordic Countries Prostate Cancer Screening Market Size, 2017-2028
6.4.8 Benelux Prostate Cancer Screening Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Screening Revenue, 2017-2028
6.5.2 China Prostate Cancer Screening Market Size, 2017-2028
6.5.3 Japan Prostate Cancer Screening Market Size, 2017-2028
6.5.4 South Korea Prostate Cancer Screening Market Size, 2017-2028
6.5.5 Southeast Asia Prostate Cancer Screening Market Size, 2017-2028
6.5.6 India Prostate Cancer Screening Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Prostate Cancer Screening Revenue, 2017-2028
6.6.2 Brazil Prostate Cancer Screening Market Size, 2017-2028
6.6.3 Argentina Prostate Cancer Screening Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Screening Revenue, 2017-2028
6.7.2 Turkey Prostate Cancer Screening Market Size, 2017-2028
6.7.3 Israel Prostate Cancer Screening Market Size, 2017-2028
6.7.4 Saudi Arabia Prostate Cancer Screening Market Size, 2017-2028
6.7.5 UAE Prostate Cancer Screening Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Prostate Cancer Screening Major Product Offerings
7.1.4 Abbott Laboratories Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Almac
7.2.1 Almac Corporate Summary
7.2.2 Almac Business Overview
7.2.3 Almac Prostate Cancer Screening Major Product Offerings
7.2.4 Almac Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.2.5 Almac Key News
7.3 Bayer
7.3.1 Bayer Corporate Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Prostate Cancer Screening Major Product Offerings
7.3.4 Bayer Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.3.5 Bayer Key News
7.4 Beckman Coulter
7.4.1 Beckman Coulter Corporate Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter Prostate Cancer Screening Major Product Offerings
7.4.4 Beckman Coulter Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.4.5 Beckman Coulter Key News
7.5 Biom?Rieux
7.5.1 Biom?Rieux Corporate Summary
7.5.2 Biom?Rieux Business Overview
7.5.3 Biom?Rieux Prostate Cancer Screening Major Product Offerings
7.5.4 Biom?Rieux Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.5.5 Biom?Rieux Key News
7.6 Genomic Health
7.6.1 Genomic Health Corporate Summary
7.6.2 Genomic Health Business Overview
7.6.3 Genomic Health Prostate Cancer Screening Major Product Offerings
7.6.4 Genomic Health Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.6.5 Genomic Health Key News
7.7 Mayo Clinic
7.7.1 Mayo Clinic Corporate Summary
7.7.2 Mayo Clinic Business Overview
7.7.3 Mayo Clinic Prostate Cancer Screening Major Product Offerings
7.7.4 Mayo Clinic Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.7.5 Mayo Clinic Key News
7.8 Mdxhealth
7.8.1 Mdxhealth Corporate Summary
7.8.2 Mdxhealth Business Overview
7.8.3 Mdxhealth Prostate Cancer Screening Major Product Offerings
7.8.4 Mdxhealth Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.8.5 Mdxhealth Key News
7.9 Roche Diagnostics
7.9.1 Roche Diagnostics Corporate Summary
7.9.2 Roche Diagnostics Business Overview
7.9.3 Roche Diagnostics Prostate Cancer Screening Major Product Offerings
7.9.4 Roche Diagnostics Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.9.5 Roche Diagnostics Key News
7.10 Rosetta Genomics
7.10.1 Rosetta Genomics Corporate Summary
7.10.2 Rosetta Genomics Business Overview
7.10.3 Rosetta Genomics Prostate Cancer Screening Major Product Offerings
7.10.4 Rosetta Genomics Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.10.5 Rosetta Genomics Key News
7.11 Thermo Fisher Scientific
7.11.1 Thermo Fisher Scientific Corporate Summary
7.11.2 Thermo Fisher Scientific Business Overview
7.11.3 Thermo Fisher Scientific Prostate Cancer Screening Major Product Offerings
7.11.4 Thermo Fisher Scientific Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.11.5 Thermo Fisher Scientific Key News
7.12 Hologic
7.12.1 Hologic Corporate Summary
7.12.2 Hologic Business Overview
7.12.3 Hologic Prostate Cancer Screening Major Product Offerings
7.12.4 Hologic Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.12.5 Hologic Key News
7.13 Myriad Genetics
7.13.1 Myriad Genetics Corporate Summary
7.13.2 Myriad Genetics Business Overview
7.13.3 Myriad Genetics Prostate Cancer Screening Major Product Offerings
7.13.4 Myriad Genetics Prostate Cancer Screening Revenue in Global Market (2017-2022)
7.13.5 Myriad Genetics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer